Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Jumia Technologies AG - ADR (JMIA) vs Altria Group Inc (MO) Price & Performance

Jumia Technologies AG - ADRTrade
Altria Group IncTrade

Price performance (Past 24H)

Key statistics

Jumia Technologies AG - ADR vs Altria Group Inc — how do they compare? Jumia Technologies AG - ADR trades at $6.23 (market cap $719.58M), while Altria Group Inc trades at $64.76 (market cap $108.58B). The key difference: Altria Group Inc is far larger — about 150.9× Jumia Technologies AG - ADR's market cap, and Altria Group Inc pays a 6.52% dividend while Jumia Technologies AG - ADR pays none. Which is the better fit depends on your goals.

JMIAMO
Market Cap
$719.58M$108.58B
Sector
Consumer CyclicalConsumer Staples
52-Week High
$14.60$74.92
52-Week Low
$5.69$54.72
Enterprise Value
$666.68M$130.79B
Dividend Yield
6.52%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Jumia Technologies AG - ADR

JMIA trades at $6.00, down 3.07% today, with a bearish technical signal. The company shows improving fundamentals with revenue growth to $189M in 2025 and narrowing losses, though it remains unprofitable with a -30.79% net margin. Analyst sentiment is positive with 71% buy ratings, supported by progress toward Q4 2026 breakeven targets and recent $50M capital raise.

The path to profitability remains the key investment thesis, with management targeting 2027 EBITDA breakeven. Risks include persistent cash burn, competitive e-commerce landscape, and execution challenges in African markets. The stock offers speculative upside if turnaround continues but carries significant operational risk.

Altria Group Inc

Altria Group (MO) trades at $65.54, down 4.11% amid bearish technical signals and mixed earnings performance. The stock shows strong fundamentals with a 39% net income margin and attractive 6.3% dividend yield, though cigarette volume declines persist. Recent Q2 2026 earnings missed expectations, triggering price weakness and multiple legal investigations into potential securities violations. Analyst consensus remains positive with 61.5% buy ratings and $67 price target, but technical indicators suggest near-term pressure with support at $62-65.

MO presents a value opportunity for income investors with its high yield and reasonable P/E of 13.7, though regulatory risks and declining traditional tobacco business create headwinds. The smoke-free product expansion offers growth potential, but legal uncertainties and volume erosion require careful monitoring. Current levels near support provide entry points for dividend-focused investors willing to accept sector-specific risks.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Jumia Technologies AG - ADR

Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates most of its revenue from the West Africa segment.

Read more on JMIA

About Altria Group Inc

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).

Read more on MO